ALPS Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $139K | Sell |
|
|||||
|
2025
Q2 | $150K | Sell |
|
|||||
|
2025
Q1 | $193K | Sell |
|
|||||
|
2024
Q4 | $226K | Buy |
|
|||||
|
2024
Q3 | $207K | Sell |
|
|||||
|
2024
Q2 | $256K | Buy |
|
|||||
|
2024
Q1 | $167K | Buy |
|
|||||
|
2023
Q4 | $171K | Sell |
|
|||||
|
2023
Q3 | $183K | Buy |
|
|||||
|
2023
Q2 | $278K | Buy |
|
|||||
|
2023
Q1 | $254K | Sell |
|
|||||
|
2022
Q4 | $284K | Buy |
|
|||||
|
2022
Q3 | $304K | Sell |
|
|||||
|
2022
Q2 | $365K | Sell |
|
|||||
|
2022
Q1 | $650K | Sell |
|
|||||
|
2021
Q4 | $1.01M | Sell |
|
|||||
|
2021
Q3 | $1.17M | Sell |
|
|||||
|
2021
Q2 | $1.57M | Sell |
|
|||||
|
2021
Q1 | $1.49M | Sell |
|
|||||
|
2020
Q4 | $1.66M | Buy |
|
|||||
|
2020
Q3 | $271K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $421K | Sell |
|
|||||
|
2019
Q3 | $356K | Buy |
|
|||||
|
2019
Q2 | $286K | Sell |
|
|||||
|
2019
Q1 | $393K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $338K | Hold |
|
|||||
|
2015
Q3 | $4.1K | Buy |
|